Skip to content

Clinical trials

Terminated Thrombocythemia, Essential trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Status: Terminated Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20061
20072
20082
20091
20101
20131
20142
20151
20171
20192
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CTI BioPharma2
M.D. Anderson Cancer Center2
Mayo Clinic2
Alliance for Clinical Trials in Oncology1
Astex Pharmaceuticals, Inc.1
Baylor College of Medicine1
City of Hope Medical Center1
Exelixis1
Fred Hutchinson Cancer Center1
H. Lee Moffitt Cancer Center and Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential22
Polycythemia Vera21
Myeloproliferative Disorders19
Primary Myelofibrosis19
Leukemia9
Leukemia, Myeloid, Acute9
Leukemia, Myelomonocytic, Chronic8
Myelodysplastic Syndromes8
Leukemia, Lymphocytic, Chronic, B-Cell7
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative7

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.